Hillon P - Search Results

1

Postprandial hemodynamic responses in patients with cirrhosis.

Lee SS, Hadengue A, Moreau R, Sayegh R, Hillon P, Lebrec D. Lee SS, et al. Among authors: hillon p. Hepatology. 1988 May-Jun;8(3):647-51. doi: 10.1002/hep.1840080335. Hepatology. 1988. PMID: 3131229

2

Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial.

Lebrec D, Poynard T, Capron JP, Hillon P, Geoffroy P, Roulot D, Chaput JC, Rueff B, Benhamou JP. Lebrec D, et al. Among authors: hillon p. J Hepatol. 1988 Aug;7(1):118-25. doi: 10.1016/s0168-8278(88)80515-4. J Hepatol. 1988. PMID: 3053888 Clinical Trial.

3

Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleeding.

Poynard T, Lebrec D, Hillon P, Sayegh R, Bernuau J, Naveau S, Chaput JC, Klepping C, Rueff B, Benhamou JP. Poynard T, et al. Among authors: hillon p. Hepatology. 1987 May-Jun;7(3):447-51. doi: 10.1002/hep.1840070306. Hepatology. 1987. PMID: 3032758

4

The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.

Lebrec D, Hillon P, Muńoz C, Goldfarb G, Nouel O, Benhamou JP. Lebrec D, et al. Among authors: hillon p. Hepatology. 1982 Sep-Oct;2(5):523-7. doi: 10.1002/hep.1840020502. Hepatology. 1982. PMID: 6981575 Clinical Trial.

5

Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis.

Hillon P, Lebrec D, Muńoz C, Jungers M, Goldfarb G, Benhamou JP. Hillon P, et al. Hepatology. 1982 Sep-Oct;2(5):528-31. doi: 10.1002/hep.1840020503. Hepatology. 1982. PMID: 7118065 Clinical Trial.

6

[Degree of portal hypertension and risk of recurrent gastrointestinal bleeding in patients with cirrhosis (author's transl)].

Jungers M, Hillon P, Lebrec D. Jungers M, et al. Among authors: hillon p. Gastroenterol Clin Biol. 1982 Apr;6(4):318-20. Gastroenterol Clin Biol. 1982. PMID: 6979487 French. No abstract available.

7

Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.

Lebrec D, Poynard T, Hillon P, Benhamou JP. Lebrec D, et al. Among authors: hillon p. N Engl J Med. 1981 Dec 3;305(23):1371-4. doi: 10.1056/NEJM198112033052302. N Engl J Med. 1981. PMID: 7029276 Clinical Trial.

8

Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats.

Hillon P, Blanchet L, Lebrec D. Hillon P, et al. Clin Sci (Lond). 1982 Jul;63(1):29-32. doi: 10.1042/cs0630029. Clin Sci (Lond). 1982. PMID: 7083761

9

[Suprahepatic pressures, portal hypertension and secondary cancer of the liver].

Hillon P, Lebrec D. Hillon P, et al. Gastroenterol Clin Biol. 1982 Feb;6(2):202. Gastroenterol Clin Biol. 1982. PMID: 7060866 French. No abstract available.

10

Early administration of vapreotide for variceal bleeding in patients with cirrhosis.

Calès P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, Bronowicki JP, Ribard D, Botta-Fridlund D, Hillon P, Besseghir K, Lebrec D; French Club for the Study of Portal Hypertension. Calès P, et al. Among authors: hillon p. N Engl J Med. 2001 Jan 4;344(1):23-8. doi: 10.1056/NEJM200101043440104. N Engl J Med. 2001. PMID: 11136956 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters